Evaluation of the role of P-glycoprotein in ivermectin uptake by primary cultures of bovine brain microvessel endothelial cells

Neurochemical Research

Volumn 23, Issue 2, 1998, Pages 203-209

  Rose, Jayna M ^a   Peckham, Sara L ^a   Scism, Jamie L ^b   Audus, Kenneth L ^a,c  

^a UNIVERSITY OF KANSAS   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY OF KANSAS   (United States)

Author keywords

Blood brain barrier; Brain microvessel endothelia; Ivermectin; P glycoprotein; Rhodamine 123

Indexed keywords

CYCLOSPORIN A; GLYCOPROTEIN P; IVERMECTIN; MONOCLONAL ANTIBODY; RHODAMINE 123; VERAPAMIL;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN MICROCIRCULATION; CATTLE; CELL MEMBRANE TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG UPTAKE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANIMALS; BRAIN; CATTLE; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FLUORESCENT DYES; IMMUNOBLOTTING; IVERMECTIN; MICROCIRCULATION; P-GLYCOPROTEIN; RHODAMINE 123; RHODAMINES;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0031912597     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022485026198     Document Type: Article

References (31)

1. Kartner, N., Riordan, J. R., and Ling, V. 1983. Cell surface Pglycoprotein associated with multidrug resistance in mammalian cell lines. Science 221:1285-1288.
2. Hegmann, E. J., Bauer, H. C., and Kerbel, R. S. 1992. Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells. Cancer Res. 52:6969-6975.
3. Jette, L., Murphy, G. F., LeClerc, J., and Beliveau, R. 1995. Interaction of drugs with P-glycoprotein in brain capillaries. Biochem. Pharmacol. 50:1701-1709.
4. Tatsuta, T., Naito, M., Oh-hara, T., Sugawara, I., and Tsuruo, T. 1992. Functional involvement of P-glycoprotein in blood-brain barrier. J. Biol. Chem. 267:20383-20391.
5. Tsuji, A., Tamai, I., Sakata, A., Tenda, Y., and Terasaki, T. 1993. Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein. Biochem. Pharmacol. 46:1096-1099.
6. Joo, F. 1993. The blood-brain barrier in vitro: the second decade. Neurochem. Int. 23:499-521.
7. Audus, K. L., Knaub, S. R., Guillot, F. L., and Schaeffer, J. M. 1992. The effect of protein binding on ivermectin uptake by bovine brain microvessel endothelial cells. Vet. Res. Commun. 16: 365-377.
8. Shi, F., Schaeffer, J. M., and Audus, K. L. 1993. Ivermectin uptake and transfer across brain microvessel endothelial cell (BMEC) monolayers from ivermectin sensitive collies. Pharm. Res. 10:413.
9. Campbell, W. C. 1985. Ivermectin: an update. Parasitology Today 1:10-16.
10. Shinkel, A. H., Smit, J. J. M., van Tellingen, O., Breijnen, J. H., Wagenaar, E., Van Deemter, L., Mol., C. A. A. M., van der Valk, M. A., Robanus-Maanday, E. C., te Riele, H. P. J., et al. 1994. Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502.
11. Chiu, S. H. L., Carlin, J. R., Taub, R., Sestokas, E., Zweig, J., VandenHeuval, W. J. A., and Jacob, T. A. 1988. Comparative metabolic disposition of ivermectin in fat tissues of cattle, sheep, and rats. Drug Metab. and Dispos. 16:728-736.
12. Egudina, S. V., Stromskaya, T. P., Frolova, E. A., and Stavrovskaya, A. A. 1993. Early steps of the P-glycoprotein expression in cell cultures studied with vital fluorochrome. FEBS Lett. 329: 63-66.
13. Lautier, D., Canitrot, Y., and Salmon, J. M. 1994. Effects of vinblastine, colchicine, and verapamil on rhodamine 123 accumulation in human P-glycoprotein-positive leukemia cells. Anticancer Res. 14:2589-2596.
14. Wang, Q., Yang, H., Miller, D. W., and Elmquist, W. F. 1995. Effect of the P-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain: an in vivo microdialysis study in freely moving rats. Biochem. Biophys. Res. Commun. 211:719-726.
15. Audus, K. L., and Borchardt, R. T. 1986. Characterization of an in vitro blood-brain barrier model system for studying drug transport and metabolism. Pharm. Res. 3:81-87.
16. Audus, K. L., and Borchardt, R. T. 1987. Bovine brain microvessel endothelial cell monolayers as a model system for the blood-brain barrier. Ann. NY Acad. Sci. 507:9-18.
17. Bowman, P. D., Ennis, S. R., Rarey, K. E., Betz, A. L., and Goldstein, G. W. 1983. Brain microvessel endothelial cells in tissue culture: a model for study of blood-brain barrier permeability. Ann. Neurol. 14:396-102.
18. Miller, D. W., Audus, K. L., and Borchardt, R. T. 1992. Application of cultured endothelial cells of the brain microvasculature in the study of the blood-brain barrier. J. Tiss. Cult. Meth. 14: 217-224.
19. Audus, K. L., Ng, L., Wang, W., and Borchardt, R. T. 1996. Brain microvessel endothelial cell culture systems. Pages 239-258, in Borchardt, R. T., Smith, P. L., and Wilson, G. (eds.), Model Systems for Biopharmaceutical Assessment of Drug Absorption and Metabolism, Plenum Publishing Corporation, New York.
20. Hidalgo, I. J., Raub, T. J., and Borchardt, R. T. 1989. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96:736-749.
21. Hosoya, K., Kim, K.-J., and Lee, V. H. L. 1996. Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers. Pharm. Res. 13:885-890.
22. Tsuruo, T., Iida, H., Nojiri, M., Tsukagoshi, S., and Sakurai, Y. 1983. Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers. Cancer Res. 43: 2905-2910.
23. Pulliam, J. D., Seward, R. L., Henry, R. T., and Steinberg, S. A. 1985. Investigating ivermectin toxicity in collies. Vet. Med. 80: 33-40.
24. Lo, P. K. A., Fink, D. W., Williams, J. B., and Blodinger, J. 1985. Pharmacokinetic studies of ivermectin: Effects of formulation. Vet. Res. Commun. 9:251-268.
25. Tranquilli, W. J., Paul, A. J., Seward, R. L., Todd, K. S., and DiPietro, J. A. 1987. Response to physostigmine administration in collie dogs exhibiting ivermectin toxicosis. J. Vet. Pharmacol. Ther. 10:96-100.
26. Schinkel, A. H., Wagenaar, E., Mol, C. A. A. M., and van Deemter, L. 1996. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest. 97:2517-2524.
27. Begley, D. J., Squires, L. K., Zlokovic, B. V., Mitrovic, D. M., Hughes, C. C. M., Revest, P.-A., and Greenwood, J. 1990. Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A. J. Neurochem. 55:1222-1230.
28. Lehnert, M., de Giuli, R., Kunke, K., Emerson, S., Dalton, W. S., and Salmon, S. E. 1996. Serum can inhibit reversal of multidrug resistance by chemosensitizers. Eur. J. Cancer 32A:862-867.
29. Rose, J. M., and Audus, K. L. 1997. Cellular mechanisms regulating losartan transfer across brain capillary endothelial cells in primary culture, s.t.p. Pharm. Sci. 7:71-77.
30. Stewart, P. A., Beliveau, R., and Rogers, K. A. 1996. Cellular localization of P-glycoprotein in brain versus gonadal capillaries. J. Histochem. Cytochem. 44:679-685.
31. Pardridge, W. M., Golden, P. L., Kang, Y. S., and Bickel, U. 1997. Brain microvascular and astrocyte localization of P-glycoprotein. J. Neurochem. 68:1278-1285.